Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017

Parth Patel; Anthony K. Guzman; Adam Tinklepaugh; David Ciocon

doi:10.36849/JDD.5909

Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017

Parth Patel, Anthony K. Guzman, Adam Tinklepaugh, David Ciocon

Medicine

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Abstract

Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.

Original language	English (US)
Pages (from-to)	905-906
Number of pages	2
Journal	Journal of Drugs in Dermatology
Volume	20
Issue number	8
DOIs	https://doi.org/10.36849/JDD.5909
State	Published - Aug 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.36849/JDD.5909

Cite this

@article{6ae33522fffb4f4aa0a144d5ad31975c,

title = "Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017",

abstract = "Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.",

author = "Parth Patel and Guzman, {Anthony K.} and Adam Tinklepaugh and David Ciocon",

year = "2021",

month = aug,

doi = "10.36849/JDD.5909",

language = "English (US)",

volume = "20",

pages = "905--906",

journal = "Journal of Drugs in Dermatology",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "8",

}

TY - JOUR

T1 - Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017

AU - Patel, Parth

AU - Guzman, Anthony K.

AU - Tinklepaugh, Adam

AU - Ciocon, David

PY - 2021/8

Y1 - 2021/8

N2 - Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.

AB - Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.

UR - http://www.scopus.com/inward/record.url?scp=85114521869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114521869&partnerID=8YFLogxK

U2 - 10.36849/JDD.5909

DO - 10.36849/JDD.5909

M3 - Letter

C2 - 34397191

AN - SCOPUS:85114521869

SN - 1545-9616

VL - 20

SP - 905

EP - 906

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

IS - 8

ER -

Immunohistochemistry Utilization in Medicare Beneficiaries by Mohs Surgeons from 2012-2017

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this